Clinical trial
Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease
NCT00003421 · Medical Research Council, Other · Completed
Key facts
| NCT number | NCT00003421 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease |
| Official title | A UKLG Randomised Trial of Initial Chemotherapy for Advanced Stage Hodgkins Disease |
| Lead sponsor | Medical Research Council, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug, Radiation |
| Interventions | bleomycin sulfate, ABVD regimen, chlorambucil, dacarbazine, doxorubicin hydrochloride, etoposide, prednisolone, procarbazine hydrochloride, vinblastine sulfate, vincristine sulfate and 1 more |
| Enrollment | 800 |
| Start date | Jun 1, 1998 |
| Completion | Nov 1, 2005 |
| First posted | Mar 12, 2004 |
| Last update posted | Dec 4, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: